Charite-Universitatsmedizin Berlin - Campus Virchow Klinikum
Berlin 13353
2 studies enrolling now · 11 studies all time
What they study most
Adenovirus, Arthritis, Juvenile, Arthritis, Psoriatic, Colitis, Ulcerative, Colorectal Neoplasms, Crohn Disease, Follicular Lymphoma, Heart Failure With Preserved Ejection Fraction, Hepatitis C, Chronic, Obstructive Hypertrophic Cardiomyopathy (oHCM), Pouchitis, Ulcerative Colitis
Studies at this site
- A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
- A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer — Recruiting now
- A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis — Completed
- A Long-term Extension Study of Ustekinumab in Pediatric Participants — Running, not enrolling
- Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM — Completed
- A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Completed
- Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis — Completed
- A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis — Completed
- The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation — Stopped early
- A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed
- GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection — Completed